Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noel D. Jones is active.

Publication


Featured researches published by Noel D. Jones.


Journal of Medicinal Chemistry | 1996

Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides.

Robert D. Dillard; Nicholas James Bach; Susan Elizabeth Draheim; Dennis R. Berry; Donald G. Carlson; Nickolay Y. Chirgadze; David K. Clawson; Lawrence W. Hartley; Lea M. Johnson; Noel D. Jones; Emma R. McKinney; Edward David Mihelich; Jennifer L. Olkowski; Richard Walter Schevitz; Amy C. Smith; David W. Snyder; Cynthia D. Sommers; Jean-Pierre Wery

Phospholipases (PLAs) produce rate-limiting precursors in the biosynthesis of various types of biologically active lipids involved in inflammatory processes. Increased levels of human nonpancreatic secretory phospholipase A2 (hnps-PLA2) have been detected in several pathological conditions. An inhibitor of this enzyme could have therapeutic utility. A broad screening program was carried out to identify chemical structures which could inhibit hnps-PLA2. One of the lead compounds generated by the screening program was 5-methoxy-2-methyl-1-(phenylmethyl)-1H-indole-3-acetic acid (13a). We describe the syntheses, structure−activity relationships, and pharmacological activities of a series of indole-3-acetamides and related compounds derived from this lead. This SAR was undertaken with the aid of X-ray crystal structures of complexes between the inhibitors and hnps-PLA2 which were of great value in directing the SAR.


Tetrahedron Letters | 1991

A83543A-D, unique fermentation-derived tetracyclic macrolides

Herbert A. Kirst; Karl H. Michel; James W. Martin; Lawrence Creemer; Eddie H. Chio; Raymond C. Yao; Walter Mitsuo Nakatsukasa; Laverne Dwaine Boeck; John L. Occolowitz; Jonathan W. Paschal; Jack B. Deeter; Noel D. Jones; Gary D. Thompson

Abstract A multi-factored complex of structurally-unique macrolides was isolated from culture broths of a new species of Saccharopolyspora. The core structure consists of a 5,6,5-cis-anti-trans-tricyclic ring system fused to a 12-membered macrocyclic lactone, which is further substituted by an amino- and a neutral sugar.


Tetrahedron | 1989

Molecular modeling of γ-lactam analogues of β-lactam antibacterial agents: synthesis and biological evaluation of selected penem and carbapenem analoques

Norris E. Allen; Donald B. Boyd; Jack B. Campbell; Jack B. Deeter; Thomas K. Elzey; Bennie Joe Foster; Lowell D. Hatfield; Joseph N. Hobbs; William Joseph Hornback; David C. Hunden; Noel D. Jones; Michael Dean Kinnick; John M. Morin; John E. Munroe; John K. Swartzendruber; David G. Vogt

Abstract Computational chemistry made possible the prediction of the three-dimensional structures of γ-lactam analogues of penems and carbapenems before the analogues were made. Molecular superpositioning showed that these novel structures with a 7β-acylamino side-chain present the pharmacophoric groups in close spatial similarity to the groups in biologically active cephalosporin and penicillin antibiotics. This suggests that 8-oxo-7-acylamino-1-azabicyclo[3.3.0]-oct-2-ene-2-carboxylates and the 4-thia-analogues can be accommodated in the same active sites of essential bacterial penicillin-binding proteins where cephalosporins and penicillins are recognized. The syntheses of these compounds are reported. The γ-lactams exhibit low, but detectable levels of antibacterial activity and suggest promise that substantial activity can be achieved with other γ-lactams.


Tetrahedron Letters | 1986

γ-Lactam analogues of carbapenems

Donald B. Boyd; Bennie Joe Foster; Lowell D. Hatfield; William Joseph Hornback; Noel D. Jones; John E. Munroe; John K. Swartzendruber

Abstract γ-Lactam analogues of carbapenems have been synthesized using a [3+2] cyclization approach. Slight antibiotic activity was observed in one case.


Bioorganic & Medicinal Chemistry Letters | 1996

D-Phe-Pro-p-Amidinobenzylamine: A potent and highly selective thrombin inhibitor

Michael Robert Wiley; Nickolay Y. Chirgadze; David K. Clawson; Trelia J. Craft; Donetta S. Gifford-Moore; Noel D. Jones; Jennifer L. Olkowski; Leonard C. Weir; Gerald F. Smith

Abstract The design, synthesis, and enzyme inhibitory profile of D-Phe-Pro-p-Amidinobenzylamine are presented. This compound has inhibitory activity equivalent to D-Phe-Pro-Arg-H, two orders of magnitude more potent than D-Phe-Pro-Agmatine. The results indicate that binding energy provided by the covalent bond of a transition-state analog can be replaced with noncovalent interactions.


Tetrahedron Letters | 1987

Bicyclic pyrazolidinones, steric and electronic effects on antibacterial activity

Louis Nickolaus Jungheim; Sandra Kay Sigmund; Noel D. Jones; John K. Swartzendruber

Abstract Bicyclic pyrazolidinones were synthesized as γ-lactam analogs of the β-lactam antibiotics. Several of these compounds exhibited broad spectrum in vitro antibacterial activity.


Bioorganic & Medicinal Chemistry Letters | 1995

Serine protease selectivity of the thrombin inhibitor D-Phe-Pro-Agmatine and its homologs

Michael Robert Wiley; Nickolay Y. Chirgadze; David K. Clawson; Trelia J. Craft; Donetta S. Gifford-Moore; Noel D. Jones; Jennifer L. Olkowski; Aaron Leigh Schacht; Leonard C. Weir; Gerald F. Smith

Abstract Analogs of D-Phe-Pro-Agmatine were assayed for inhibititory activity versus thrombin, trypsin, plasmin, n-tPA and urokinase. The X-ray structure of the thrombin/D-Phe-Pro-Agmatine co-crystal revealed that the agmatine and analogous arginals have very similar bound conformations.


Biochemical and Biophysical Research Communications | 1973

Pyrazomycin B: Isolation and characterization of an α-C-nucleoside antibiotic related to pyrazomycin

Gerald E. Gutowski; Michael O. Chaney; Noel D. Jones; Robert L. Hamill; Fred A. Davis; Roger D. Miller

Abstract This communication reports the isolation and structure of pyrazomycin B, the α-anomer of the anti-tumor and anti-viral antibiotic pyrazomycin. Spectral, chemical and x-ray crystallographic evidence is provided.


Tetrahedron Letters | 1984

C(3)-azido cephem II

Douglas O. Spry; Anita R. Bhala; Wayne A. Spitzer; Noel D. Jones; John K. Swartzendruber

Abstract The major product from the thermolysis and photolysis of C(3)-azido cephem 2 is the ring expanded 1,4,6-thiadiazepine azetidinone.


Bioorganic & Medicinal Chemistry Letters | 1995

N-substituted glycines as replacements for proline in tripeptide aldehyde thrombin inhibitors

Aaron Leigh Schacht; Michael Robert Wiley; Nickolay Y. Chirgadze; David K. Clawson; Trelia J. Craft; William J. Coffman; Noel D. Jones; Donnetta Gifford-Moore; Jennifer L. Olkowski; Robert Theodore Shuman; Gerald F. Smith; Leonard C. Weir

Abstract We have prepared a series of tripeptide arginine aldehydes in which the P2 proline has been replaced with a variety of N -substituted glycines. The effects of these modifications on thrombin inhibitory potency and serine protease selectivity were evaluated.

Collaboration


Dive into the Noel D. Jones's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge